Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01362283
NCT01362283CompletedNot Applicable

A Multi-center, Observational, Cross-sectional Study to Evaluate CVD Risk Factors in Korean Hypertensive Patients

GlaxoSmithKline0 sites3,109 target enrollmentStarted: August 2010Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
3,109
Primary Endpoint
Proportion of patients with cardiovascular disease high risk factors
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is investigating the proportion of Cardiovascular disease risk factors of hypertensive patients.

Detailed Description

Primary endpoint: To evaluate the Proportion of patients with Cardiovascular disease high risk factors

Secondary endpoint: To evaluate the Proportion of patients with Cardiovascular disease risk factors, To evaluate the Proportion of patients with Cardiovascular disease, To evaluate Target blood pressure achievement rate according to the proportion of Cardiovascular disease risks

Study Design

Study Type
Observational
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Essential hypertensive patient no less than 18 yeas old
  • •Patient who gave informed consent form

Exclusion Criteria

  • •Patient was diagnosed as secondary hypertension
  • •Patient who have white-coat hypertension

Outcomes

Primary Outcomes

Proportion of patients with cardiovascular disease high risk factors

Time Frame: 6years, average duration of hypertension

Between patients with essential hypertension

Secondary Outcomes

  • Proportion of patients with Cardiovascular disease(6years, average duration of hypertension)
  • Proportion of patients with Cardiovascular disease risk factors(6years, average duration of hypertension)
  • Target Blood Pressure achievement rate according to the proportion of Cardiovascular disease risks(6years, average duration of hypertension)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Completed
Not Applicable
Cardiovascular Risk Factors on Electrocardiographically and Hemodynamics Responses to Treadmill Exercise TestCardiovascular DiseasesCardiovascular AbnormalitiesHealthy
NCT05987891University of Sao Paulo400
Completed
Not Applicable
A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in PortugalDiabetes Mellitus, Type 2
NCT03797885Novo Nordisk A/S730
Unknown
Not Applicable
Cardiovascular Epidemiology in Russian FederationSmokingLifestyleHypertensionHeart FailureDiabetesCoronary Artery Disease
NCT02449460Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health18,000
Unknown
Not Applicable
Association of Multiple CardiOvascular Risk Factors and Erectile Function Across EuropeCardiovascular High-RiskChronic Heart Failure
NCT00468637University Hospital, Saarland1,200
Withdrawn
Not Applicable
Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)Metabolic Syndrome
NCT02069717Daewoong Pharmaceutical Co. LTD.